ERC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 


Receive this page by email each issue: [Sign up for eTOCs]


Other Issues:
Contents: July 2005, Volume 12, Issue Supplement_1   [Index by Author] 
Growth factor signalling and therapeutic resistance in breast cancer
       Consensus Statement
       Conference Papers
Find articles in this issue containing these words:
[Search ALL Issues]


To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Consensus Statement:

J M W Gee, A Howell, W J Gullick, C C Benz, R L Sutherland, R J Santen, L-A Martin, F Ciardiello, W R Miller, M Dowsett, P Barrett-Lee, J F R Robertson, S R Johnston, H E Jones, A E Wakeling, R Duncan, and R I Nicholson
Consensus Statement
Endocr Relat Cancer 2005 12: S1-S7. [Abstract] [Full Text] [PDF]  

Conference Papers:

Anthony Howell and Andrew M Wardley
Overview of the impact of conventional systemic therapies on breast cancer
Endocr Relat Cancer 2005 12: S9-S16. [Abstract] [Full Text] [PDF]  

L A Bazley and W J Gullick
The epidermal growth factor receptor family
Endocr Relat Cancer 2005 12: S17-S27. [Abstract] [Full Text] [PDF]  

R I Nicholson, I R Hutcheson, S E Hiscox, J M Knowlden, M Giles, D Barrow, and J M W Gee
Growth factor signalling and resistance to selective oestrogen receptor modulators and pure anti-oestrogens: the use of anti-growth factor therapies to treat or delay endocrine resistance in breast cancer
Endocr Relat Cancer 2005 12: S29-S36. [Abstract] [Full Text] [PDF]  

Y Zhou, S Eppenberger-Castori, U Eppenberger, and C C Benz
The NFB pathway and endocrine-resistant breast cancer
Endocr Relat Cancer 2005 12: S37-S46. [Abstract] [Full Text] [PDF]  

Alison J Butt, Catriona M McNeil, Elizabeth A Musgrove, and Robert L Sutherland
Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E
Endocr Relat Cancer 2005 12: S47-S59. [Abstract] [Full Text] [PDF]  

R J Santen, R X Song, Z Zhang, R Kumar, M-H Jeng, A Masamura, J Lawrence, Jr, L Berstein, and W Yue
Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity
Endocr Relat Cancer 2005 12: S61-S73. [Abstract] [Full Text] [PDF]  

Lesley-Ann Martin, Ian Farmer, Stephen R D Johnston, Simak Ali, and Mitch Dowsett
Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation
Endocr Relat Cancer 2005 12: S75-S84. [Abstract] [Full Text] [PDF]  

Cindy M Staka, Robert I Nicholson, and Julia M W Gee
Acquired resistance to oestrogen deprivation: role for growth factor signalling kinases/oestrogen receptor cross-talk revealed in new MCF-7X model
Endocr Relat Cancer 2005 12: S85-S97. [Abstract] [Full Text] [PDF]  

J M Gee, J F Robertson, E Gutteridge, I O Ellis, S E Pinder, M Rubini, and R I Nicholson
Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer
Endocr Relat Cancer 2005 12: S99-S111. [Abstract] [Full Text] [PDF]  

M Dowsett, S Johnston, L-A Martin, J Salter, M Hills, S Detre, M C Gutierrez, S K Mohsin, J Shou, D C Allred, R Schiff, C K Osborne, and I Smith
Growth factor signalling and response to endocrine therapy: the Royal Marsden Experience
Endocr Relat Cancer 2005 12: S113-S117. [Abstract] [Full Text] [PDF]  

W R Miller, T J Anderson, S White, D Evans, A Krause, and J M Dixon
Growth factor signalling in clinical breast cancer and its impact on response to conventional therapies: the Edinburgh experience
Endocr Relat Cancer 2005 12: S119-S123. [Abstract] [Full Text] [PDF]  

P J Barrett-Lee
Growth factor signalling in clinical breast cancer and its impact on response to conventional therapies: a review of chemotherapy
Endocr Relat Cancer 2005 12: S125-S133. [Abstract] [Full Text] [PDF]  

A Agrawal, E Gutteridge, J M W Gee, R I Nicholson, and J F R Robertson
Overview of tyrosine kinase inhibitors in clinical breast cancer
Endocr Relat Cancer 2005 12: S135-S144. [Abstract] [Full Text] [PDF]  

S R D Johnston
Clinical trials of intracellular signal transductions inhibitors for breast cancer — a strategy to overcome endocrine resistance
Endocr Relat Cancer 2005 12: S145-S157. [Abstract] [Full Text] [PDF]  

Roberto Bianco, Teresa Troiani, Giampaolo Tortora, and Fortunato Ciardiello
Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy
Endocr Relat Cancer 2005 12: S159-S171. [Abstract] [Full Text] [PDF]  

H E Jones, J M W Gee, K M Taylor, D Barrow, H D Williams, M Rubini, and R I Nicholson
Development of strategies for the use of anti-growth factor treatments
Endocr Relat Cancer 2005 12: S173-S182. [Abstract] [Full Text] [PDF]  

A E Wakeling
Inhibitors of growth factor signalling
Endocr Relat Cancer 2005 12: S183-S187. [Abstract] [Full Text] [PDF]  

R Duncan, M J Vicent, F Greco, and R I Nicholson
Polymer–drug conjugates: towards a novel approach for the treatment of endrocine-related cancer
Endocr Relat Cancer 2005 12: S189-S199. [Abstract] [Full Text] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society for Endocrinology.